#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Langerhans cell sarcoma Phaeochromocytoma Spinal cord injury Post transplant lymphoproliferative disorder Arteriovenous malformation Cutaneous T-cell lymphoma stage I Familial amyotrophic lateral sclerosis Pouchitis Neutropenia Duchenne muscular dystrophy gene carrier Acquired ATTR amyloidosis Glomerulonephritis chronic Osteosarcoma metastatic Short stature Transitional cell cancer of the renal pelvis and ureter More trials…

    Learn about Rare Diseases

    Proteus syndrome – Treatment Osteosarcoma recurrent – Life with Disease Cholangitis sclerosing – Diagnostics Basal cell naevus syndrome – Basic Information Friedreich’s ataxia – Trials in Disease Lennox-Gastaut syndrome – Diagnostics Undifferentiated sarcoma – Basic Information Mantle cell lymphoma stage IV Wiskott-Aldrich syndrome – Treatment Haemophagocytic lymphohistiocytosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Remifentanil Hydrochloride Ripretinib Enmetazobactam Juniper Berry Oil Doconexent Ethambutol Hydrochloride Boserolimab Cldn6 Car-T Iodine (123I) Iobenguane Estriol Spesolimab FERUMOXTRAN-10 Vibozilimod Pertechnetate (99Mtc) Sodium Hyoscine HUMAN PLASMA [11C]Az14193391 Orlistat Ketamine Hydrochloride Ficlatuzumab More therapies…

    Learn about Your Condition

    Congenital myopathy Aortic valve stenosis Osteochondrodysplasia Lymphocytic leukaemia Adenocarcinoma of colon Wiskott-Aldrich syndrome Coronary artery dissection Peritonitis Hepatobiliary cancer Partial seizures Stress urinary incontinence Cutibacterium acnes infection Asplenia Vulvovaginal pruritus Hypervolaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Laiko General Hospital Of Athens

Laiko General Hospital Of Athens

Messogion Avenue 152, Athens, 115 27, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Study of ibuzatrelvir alone or combined with remdesivir in adults with COVID-19 who have severely compromised immune systems

    Recruiting

    3 1
    Investigated Drugs:
    • IBUZATRELVIR
    • Remdesivir
    Belgium Denmark France Germany Greece The Netherlands +3

  • Study of Port Delivery System with ranibizumab given every 36 weeks in patients with neovascular age-related macular degeneration

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Age-related macular degeneration
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • Ranibizumab
    Austria Czechia Denmark France Germany Greece +3

  • Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

    Recruiting

    3 1
    Investigated Drugs:
    • Maridebart Cafraglutide
    Austria Belgium Bulgaria Czechia Denmark Finland +12

  • Study of fosmanogepix compared to standard antifungal drugs for treating invasive mold infections in adults

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Amphotericin B
    • Anidulafungin
    • Caspofungin Acetate
    Austria Belgium France Germany Greece Italy +2

  • Study of BMS-986482 alone or with nivolumab, relatlimab or bevacizumab in patients with advanced solid tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Bevacizumab
    • Nivolumab
    • Relatlimab
    Belgium Denmark France Greece Italy The Netherlands +2

  • Study on the Effects and Safety of Rilzabrutinib for Adults with Graves’ Disease

    Recruiting

    2 1 1
    Investigated Drugs:
    • Rilzabrutinib
    Germany Greece Hungary Italy Spain

  • Study of mRNA-4157 and Pembrolizumab for Patients with Metastatic Melanoma

    Recruiting

    2 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Mrna-4157
    • Pembrolizumab
    France Germany Greece Italy Poland Portugal +1

  • Study Comparing Golcadomide and Rituximab with Other Treatments for Patients with Relapsed or Refractory Follicular Lymphoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Bendamustine Hydrochloride
    • Betamethasone Sodium Phosphate
    • Cyclophosphamide
    Finland France Germany Greece Italy The Netherlands +2

  • Vusolimogene Oderparepvec with Nivolumab for Advanced Melanoma Patients Whose Cancer Progressed After Previous Immunotherapy Treatments

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Dacarbazine Citrate
    • Nivolumab
    • Paclitaxel
    France Germany Greece Italy Poland Spain

  • Study of Sigvotatug Vedotin and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Pembrolizumab
    • SIGVOTATUG VEDOTIN
    Austria Belgium Bulgaria Czechia Denmark France +9
Previous Page
1 … 7 8 9 10 11 … 38
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!